Product image of Norditropin Flexpro (Somatropin) supplied by GNH India

Norditropin Flexpro

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a human growth hormone presented as a recombinant protein for subcutaneous use. It is used to treat growth hormone deficiency and related growth disorders in children and adults.

GNH India supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Flexpro provides recombinant human growth hormone therapy for several endocrine and genetic growth disorders.

  • Growth hormone deficiency: restores normal growth velocity and improves body composition.
  • Turner syndrome: promotes linear growth and helps achieve near‑normal adult height.
  • Chronic renal insufficiency: supports growth in children with renal disease.
  • Prader‑Willi syndrome: improves growth parameters and body composition.
  • Short stature associated with Noonan syndrome: enhances height outcomes during childhood.

How It Works

  • Somatropin binds to specific growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling pathway. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1), which mediates anabolic effects, promotes linear bone growth, protein synthesis, and influences carbohydrate and lipid metabolism throughout the body.

Side Effects

Norditropin Flexpro may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Injection site pain or erythema
  • Headache
  • Transient edema of the extremities
  • Joint stiffness or arthralgia
  • Nausea or abdominal discomfort
  • Hyperglycemia or impaired glucose tolerance

Serious or Rare Side Effects

  • Intracranial hypertension
  • Development of anti‑growth hormone antibodies
  • Slipped capital femoral epiphysis
  • Acute pancreatitis
  • Severe allergic reactions (anaphylaxis)
  • Increased intracranial pressure leading to visual disturbances

Precautions & Warnings

Before initiating therapy, clinicians should evaluate relevant medical history and monitor patients regularly.

  • Assess baseline IGF‑1 levels: adjust dose based on serial measurements.
  • Monitor glucose metabolism: watch for hyperglycemia, especially in diabetic patients.
  • Screen for intracranial hypertension: be alert to headaches and visual changes.
  • Evaluate for scoliosis progression: regular orthopedic assessments are recommended.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin may interact with other agents that affect glucose homeostasis or hormone pathways.

Major Interactions (Avoid)

  • High‑dose glucocorticoids: may blunt growth‑promoting effects.
  • Insulin or oral hypoglycemics: increased risk of hypoglycemia when combined with somatropin‑induced insulin resistance.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: somatropin can increase thyroxine requirements.
  • Estrogen therapy: may enhance IGF‑1 response, requiring dose adjustment.
  • Anabolic steroids: additive effects on growth may increase risk of adverse musculoskeletal events.

Frequently Asked Questions

Norditropin Flexpro provides recombinant human growth hormone for patients with growth hormone deficiency, Turner syndrome, chronic renal insufficiency, Prader‑Willi syndrome, and short stature associated with Noonan syndrome. It helps promote linear growth and improve body composition in these disorders.

Somatropin binds to growth hormone receptors, activating intracellular signaling that increases hepatic production of insulin‑like growth factor‑1 (IGF‑1). IGF‑1 then stimulates bone growth, protein synthesis, and metabolic processes that support normal growth and development.

The dose of Norditropin Flexpro is individualized. A qualified prescriber determines the appropriate amount based on the patient’s age, weight, IGF‑1 levels, and specific indication, following clinical guidelines.

Safety of somatropin in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Norditropin Flexpro is a recombinant human growth hormone similar in efficacy to other approved somatropin products. Differences may lie in device design, formulation stability, and packaging, but clinical outcomes depend on appropriate dosing and patient monitoring.

Store Norditropin Flexpro at 2‑8 °C (refrigerated). Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the product to maintain stability.

Norditropin Flexpro is given by subcutaneous injection, typically into the thigh, abdomen, or upper arm. The injection site should be rotated with each dose, and administration technique should follow the prescriber’s instructions.

Serious risks include intracranial hypertension, development of anti‑growth hormone antibodies, slipped capital femoral epiphysis, and severe allergic reactions. Patients should be monitored regularly for signs of these conditions.

Norditropin Flexpro is contraindicated in patients with active malignancy, uncontrolled diabetes, severe acute illness, or known hypersensitivity to somatropin or any excipients. It should also be used with caution in individuals with intracranial hypertension or active proliferative retinopathy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT